• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Intermountain Healthcare, MDClone collaborate to transform patient data into actionable insight

Bioengineer by Bioengineer
January 29, 2019
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Intermountain Healthcare has announced a new collaboration with Israeli healthcare IT company MDClone to increase caregivers’ ability to transform data into information they can use to help people lead the healthiest lives possible.

As part of this new collaboration, MDClone will share a new approach to healthcare data access, analytics, and research with Intermountain.

Intermountain has long been at the forefront of digital health innovation. The new partnership will further transform its existing rich data sources into more meaningful information that will enable caregivers to deliver the best care possible to patients.

The critical part of the process will involve loading Intermountain Healthcare’s data into MDClone’s Sandbox within the walls of Intermountain, then evaluating the data longitudinally — looking at the patients’ complete medical histories from start to finish in one place — to understand critical decision points in a patient’s care.

MDClone’s Sandbox includes unique safeguards to protect patient privacy that produce synthetic data without risk of exposing patient identity. Altogether, the system allows caregivers within Intermountain to ask and answer important questions on demand to better manage patients while protecting patient privacy.

“We’re proud to continue fostering digital health innovation in this exciting partnership with MDClone,” said Mike Phillips, MD, managing director of Intermountain Ventures. “Gathering good patient data is essential to our mission, but the key is unlocking it to pull out the most meaningful information and applying it in ways that bring value to the caregiver, the health system, and most importantly, the patient. This collaboration will help us do just that.”

Ziv Ofek, CEO of MDClone, added: “As we unlock healthcare data, we have an endless potential to learn. Our mission at MDClone, however, doesn’t end there, which is why we’re thrilled to begin working with Intermountain, one of the country’s most innovative health systems. With the expertise from Intermountain’s teams, we’ll unlock its vast data and turn that data into insights and ultimately into higher-quality and lower-cost patient care in Utah and beyond.”

As chronic and acute conditions continue to drive up the cost of healthcare for many patients, Intermountain and MDClone have already identified several clinical priorities that will enhance patient care and reduce treatment costs.

Examples include chronic heart failure, kidney disease, and stroke care. The first focus of the Intermountain/MDClone collaboration will explore kidney disease and end-stage renal disease, which can cost the average patient $250,000 a year or more.

This effort will allow Intermountain to leverage MDClone’s ability to analyze medical records over the short- and long-term to identify groups of patients with all stages of kidney disease with the ultimate goal of treating and preventing their progression to end-stage renal disease.

“Not only will this help us keep patients healthier by identifying diseases before they advance, but it will also spare them the burdensome costs of treating those conditions as they progressively worsen,” said Titte R. Srinivas, MD, a nephrologist in the Intermountain Transplant Clinic.

“We look forward to the opportunity to engage this approach to keep our patients healthier in partnership with MDClone,” he said. “This technology will help us to identify trends and key decision points in treating kidney disease and apply that knowledge to help prevent patients from progressing to end-stage renal disease. It’s a game-changer for the delivery of safer, more cost-effective, higher-quality care.”

###

About Intermountain Healthcare

Intermountain Healthcare is a Utah-based, not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with 1,500 employed physicians, a health plans division called SelectHealth, and other health services. Helping people live the healthiest lives possible, Intermountain is widely recognized as a leader in clinical quality improvement and in efficient healthcare delivery.

About MDClone

MDClone unlocks healthcare data, enabling limitless exploration, discovery and collaboration. With MDClone’s synthetic data, on-demand access to data with zero-risk to patient privacy is now possible, and its Healthcare Data Sandbox is the groundbreaking environment which connects anyone across the healthcare ecosystem to the data and insights needed to transform care. Founded by industry veterans, MDClone is based in Israel with offices in the U.S. and Europe.

Media Contact
Jess C. Gomez
jess.gomez@imail.org
801-718-8495

Tags: cancerCardiologyDiagnosticsHealth ProfessionalsInformation Management/Tracking SystemsMedicine/HealthMetabolism/Metabolic Diseases
Share12Tweet8Share2ShareShareShare2

Related Posts

Multisite Awake Surgery Maintains Functional Outcomes in Multicentric IDH-Mutant Glioma Patients

Multisite Awake Surgery Maintains Functional Outcomes in Multicentric IDH-Mutant Glioma Patients

November 16, 2026
Limited Tissue Sampling May Misclassify Claudin 18 Expression in Cholangiocarcinoma

Limited Tissue Sampling May Misclassify Claudin 18 Expression in Cholangiocarcinoma

November 16, 2026

Immunotherapy Improves Advanced Esophageal Squamous-Cell Carcinoma Survival Across Most Smoking Groups

November 16, 2026

Acute Diencephalic Syndrome Frequent in Transventricular Surgery for Third-Ventricular Giant Pituitary Adenomas

November 16, 2026
Please login to join discussion

POPULAR NEWS

  • Information-Based Prescription Review Systems Evolve from Manual Screening to Intelligent Interception

    Information-Based Prescription Review Systems Evolve from Manual Screening to Intelligent Interception

    29 shares
    Share 12 Tweet 7
  • Study Reveals Incidence of Rare Pediatric Hip Disorders in Japanese Children

    29 shares
    Share 12 Tweet 7
  • Children With Nephrotic Syndrome Exhibit Severe Disruption Across Gut Microbial Kingdoms

    29 shares
    Share 12 Tweet 7
  • Automated Platform Maps Genomic Hotspots in CHO Cells for Antibody Production

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Phenazine Mediators Enable Selective Hydrogenation of Nitro Compounds at Biphasic Interfaces

Information-Based Prescription Review Systems Evolve from Manual Screening to Intelligent Interception

Study Reveals Incidence of Rare Pediatric Hip Disorders in Japanese Children

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.